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Abstract
Background: Colorectal cancer (CRC) is the third most commonly diagnosed cancer in Canada and accounts for
11.9% of all cancer-related mortality. Fortunately, previous studies have provided evidence of improved outcomes
from access to timely and appropriate health services along the disease trajectory in CRC. As a result, the CIHR/
CCNS Team in Access to Colorectal Cancer Services in Nova Scotia (Team ACCESS) was created to build colorectal
cancer (CRC) research capacity in Nova Scotia (NS) and to study access to and quality of CRC services along the
entire continuum of cancer care.
Objectives: The objectives of this paper are to: 1) provide a detailed description of the methodologies employed
across the various studies being conducted by Team ACCESS; 2) demonstrate how administrative health data can
be used to evaluate access and quality in CRC services; and 3) provide an example of an interdisciplinary team
approach to addressing health service delivery issues.
Methods: All patients diagnosed with CRC in NS between 2001 and 2005 were identified through the Nova Scotia
Cancer Registry (NSCR) and staged using the Collaborative Stage Data Collection System. Using administrative
databases that were linked at the patient level, Team ACCESS created a retrospective longitudinal cohort with
comprehensive demographic, clinical, and healthcare utilization data. These data were used to examine access to
and quality of CRC services in NS, as well as factors affecting access to and quality of care, at various transition
points along the continuum of care. Team ACCESS has also implemented integrated knowledge translation
strategies targeting policy- and decision- makers.
Discussion: The development of Team ACCESS represents a unique approach to CRC research. We anticipate that
the skills, tools, and knowledge generated from our work will also advance the study of other cancer disease sites
in NS. Given the increasing prevalence of cancer, and with national and provincial funding agencies promoting
collaborative research through increased funding for research team development, the work carried out by Team
ACCESS is important in the Canadian context and exemplifies how a team approach is essential to
comprehensively addressing issues surrounding not only cancer, but other chronic diseases in Canada.
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1. Background
1.1. Colorectal Cancer
In Canada, an estimated 22,200 new cases of colorectal
cancer (CRC) were diagnosed in 2011, making it the
third most commonly diagnosed cancer in both men
and women in Canada [1]. Despite a modest decrease in
national mortality rates over the last 20 years, CRC
mortality still accounts for approximately 11.9% of can-
cer-related deaths [1].
Nova Scotia (NS) has the second highest incidence
rate of CRC of all Canadian provinces, with an esti-
mated 830 new cases in 2011 [1]. Interestingly, esti-
mated mortality rates are higher (30 vs. 25 per 100, 000
people) [1] and estimated 5-year relative survival rates
are lower in NS (56% vs. 62%) [2] compared to Canada,
suggesting poorer patient outcomes for CRC patients in
NS than other provinces. Previous studies have provided
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and appropriate health services along the disease trajec-
tory in CRC and other malignancies [3,4], highlighting
the need for improved research into CRC services in NS.
1.2. Team ACCESS
Team ACCESS was formed in 2007 after receiving a
New Emerging Team (NET) grant from the Canadian
Institutes of Health Research (CIHR). These grants are
awarded to encourage the formation of new research
teams and to build capacity in new and developing areas
of research. Team ACCESS is an interdisciplinary team
consisting of more than 20 researchers and decision-
makers (i.e., clinicians, program managers/directors, pol-
icy-makers) from a broad range of methodological and
health disciplines. Collectively, Team ACCESS possesses
expertise in health services research, epidemiology, bios-
tatistics, population health, health administration, pri-
mary care, psychiatry, pediatrics, pathology, and surgical,
medical, and radiation oncology. Through this unprece-
dented collaborative research effort in NS, Team
ACCESS has sought to improve the capacity to examine
access to and quality of CRC services at transition
points across the entire continuum of cancer care (i.e.,
presentation of signs/symptoms, diagnosis, surgery, sys-
temic and radiation therapy, follow-up care, and
advanced disease/palliative care). Such transitions may
be particularly susceptible to problems of access and
quality since they often require patients to move across
health care sectors as part of a complex and fragmented
delivery system [5].
The specific research objectives of Team ACCESS are
to; 1) develop tools to measure and improve timely and
equitable access to, and quality of, CRC services along
the cancer care continuum, 2) explore methods to inte-
grate access and quality relevant to CRC services, and
measure the impact on outcomes, and, 3) develop and
test methods for the knowledge transfer of findings
towards improving access to quality CRC care.
Importantly, at the time this award was received,
Team ACCESS was the only team in Canada that was
examining CRC health services across the entire conti-
nuum of care. After four years of research in this area,
we know of no other group in Canada that is examining
CRC in such a comprehensive manner.
2. Objectives
The aim of this paper is to provide an account of the
expertise and preliminary work required to study CRC
services along the cancer care continuum. Specifically,
the objectives of this paper are to: 1) provide a detailed
description of the methodologies employed across the
various studies being conducted by Team ACCESS;2 )
demonstrate how administrative health data can be used
to evaluate access and quality in CRC services; and 3)
provide an example of an interdisciplinary team
approach to addressing health service delivery issues.
3. Methods
Team ACCESS h a se m b a r k e do nm o r et h a n2 0s t u d i e s
to date (Table 1), with most now completed or nearing
completion. These studies span the entire continuum of
care, from presentation of signs/symptoms, to diagnosis,
treatment, follow-up care, and advanced disease/pallia-
tive care. While the methods used may vary from study
to study (depending on the research question), the
methods presented in this section are common to all
studies.
3.1. Cohort Identification
To maximize generalizability, a population-based cohort
was identified. All incident cases of CRC (ICD-O-3:
C18, C19, C20) in NS between 2001 and 2005 were
identified through the Nova Scotia Cancer Registry
(NSCR). To define the study cohort, we excluded; 1)
cases diagnosed by death certificate only or autopsy, 2)
individuals less than 20 years of age, and 3) diagnoses of
appendix cancer (ICD-O-3: C18.1), lymphoma, non-
invasive CRC, and invasive Stage 0 CRC [6]. For patients
with more than one CRC diagnosis in the time period,
we kept only one record per patient (Figure 1). Of the
selected 3,501 patients that comprise the final study
cohort, 2,385 (68.1%) had colon cancer and 1,116
(31.9%) had rectal cancer. Their demographic and dis-
ease characteristics are described in Table 2.
3.2. Cohort Staging
Since treatment for CRC depends on stage at diagnosis
[7], stage data are key in examining issues surrounding
timely receipt of quality care and the impact on patient
outcomes. In Canada, staging data have not historically
been collected by provincial cancer registries [8], as was
the case in NS. Upon cohort identification, Team
ACCESS collaborated with experienced coders at the
NSCR to conduct an extensive chart review and stage
all CRC cases using the Collaborative Stage (CS) Data
Collection System, resulting in CS derived AJCC stage
groups [6,9]. CS uses information from multiple sources
to determine a “best” stage, effectively reducing the
number of unknown stages within a population [10],
contributing to the completeness of our data.
3.3. Data Sources
At the center of Team ACCESS research is a longitudi-
nal ‘database’ assembled by linking individual patient
records across the administrative health databases used
in the study. Complete data (i.e. data from all databases)
are available from January 1, 1999 to March 31, 2008.
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Page 2 of 8The earlier years of data permit the study of healthcare
utilization for the two years preceding diagnosis for all
patients in the cohort. Table 3 presents the databases
used by Team ACCESS,a sw e l la st h em a i nv a r i a b l e s
extracted from each database.
As previously discussed, the cohort was identified
through the NSCR. In NS, all new cancer diagnoses are
reportable to the NSCR by law. The NSCR is operated
by the Surveillance and Epidemiology Unit (SEU) at
Cancer Care Nova Scotia (CCNS) and has data dating
back to 1964. In NS, the SEU houses both the NSCR
and the Oncology Patient Information System (OPIS),
the administrative scheduling system for the province’s
two tertiary care cancer centres, resulting in a single
database that contains both cancer registry and cancer
centre data. Thus, for each patient included in the
cohort, the following information was extracted from
NSCR/OPIS: patient demographics, previous and subse-
quent primary cancers, diagnosis and staging, cancer
center referrals, treatment-related and cancer recurrence
visits, and radiotherapy treatments.
Through the Population Health Research Unit (PHRU)
at Dalhousie University, we accessed and linked infor-
mation from a variety of administrative health care data-
bases [11]. The NS Department of Health (DoH)
supplies PHRU with complete Medicare and hospital
files suitable for research purposes. In accordance with
DoH policy, all data held at PHRU uses an encrypted
health card number to maintain patient confidentiality.
Other databases, held at individual departments/pro-
grams, were used by Team ACCESS to obtain additional
information relevant to CRC services and/or patients.
Table 1 Summary of Team ACCESS research
Area of Study Research Question/Study Theme(s)
From screening/symptoms to
diagnosis
What are the peri-diagnostic time intervals for CRC care? What factors affect receipt of timely care? Access
What factors related to pre-CRC diagnosis health care utilization are associated with late stage diagnosis
of CRC?
Access,
Quality
Using micro-simulation, how will introduction of a population-based screening program impact on
resource and health services utilization?
Access
From diagnosis to surgery What are the surgical time intervals for CRC care? What factors affect receipt of timely care? Access
Are there differences in the use of health care services for emergency vs. elective presentation of CRC? Access,
Quality
Has adequate lymph node assessment improved over time? Quality
What are the effects of lymph node assessment on overall CRC survival? Quality
Exploring Stage IIB survival: can we identify factors associated with poor outcomes in Stage IIB patients? Access,
Quality
Timely access to and quality of care in CRC: are they related? Access,
Quality
From surgery to adjuvant
treatment
(chemotherapy/
radiotherapy)
What are the treatment time intervals for adjuvant CRC care? What factors affect receipt of timely care? Access
Is adjuvant therapy administered in accordance with established clinical practice guidelines? Access,
Quality
What are the reasons for non-adherence to guidelines? Quality
Does inequity exist in meeting established benchmarks for radiotherapy and in receipt of treatment? Access,
Quality
What is the completeness of colonoscopy, surgery, and pathology reporting for rectal cancer patient
receiving radiotherapy?
Quality
From adjuvant treatment to
follow-up care
What are the patterns of follow-up care for CRC? Access,
Quality
Is follow-up care being provided according to established clinical practice guidelines? Access,
Quality
How do patients feel about the follow-up care they receive? Access,
Quality
Are CRC survivors receiving appropriate screening services for other cancers? Access
End-of-life care What are the patterns of medication use amongst end-of-life CRC patients? Access,
Quality
Does inequity exist in health care utilization for CRC patients at end-of life? Access
Knowledge Translation Which approaches/strategies are useful in integrating research findings into clinical practice?
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Authority’s Radiology Department (CHRD) database,
Capital District Health Authority’s and Cape Breton Dis-
trict Health Authority’s Palliative Care Program (PCP)
databases, the CCNS Cervical Cancer Prevention Pro-
gram (CCPP) database, and the Nova Scotia Breast
Screening Program (NSBSP) database.
3.4. Data Linkage
To facilitate data linkage, a unique study ID was
appended to each of the identified NSCR records. As
s h o w ni nF i g u r e2 ,d a t al i n k a g ec o n s i s t e do ft w o
processes:
1) To link NSCR data to PHRU data, the health card
number (HCN) and unique study ID from the identi-
fied records were sent to the provincial healthcare
administrator for HCN encryption. The unique study
ID and encrypted HCN were then sent to PHRU. The
information contained within the NSCR records (i.e.,
staging, demographics, cancer clinic visit activity, etc.)
was sent directly to PHRU with only the unique study
ID as a person-level identifier. Using the unique study
ID, the encrypted HCN was re-assigned to the corre-
sponding patient record to enable linkage to PHRU
data.
2) To link NSCR data to the remaining databases,
patient identifiers (i.e., HCN, date of birth, surname)
Figure 1 Cohort identification.
Table 2 Characteristics of study cohort
Cohort Characteristics n (%)
Sex
Female 1634(46.7)
Male 1867(53.3)
Age at Diagnosis
20-64 1122(32.0)
65-74 941(26.9)
75+ 1438(41.1)
Rural/urban residence
Rural 1424(40.7)
Urban 2077(59.3)
Comorbidity score
0 2031(58.0)
1+ 1470(42.0)
Collaborative stage
I 659(18.8)
II 1069(30.5)
IIA 882(25.2)
IIB 187(5.3)
III 916(26.2)
IIIA 88(2.5)
IIIB 555(15.9)
IIIC 273(7.8)
IV 697(19.9)
Unknown 160(4.6)
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the dataset custodians at CHRD, PCP, CCPP, and
NSBSP. All records that corresponded to patients in our
cohort were identified within each database using the
HCN and confirmed using the patient identifiers. The
data custodian then extracted these records, removed all
identifying information from the file, except the unique
study ID, and sent the file to PHRU for linkage to
NSCR records via unique study ID.
3.5. Measures
3.5.1. Overarching Themes
The themes of access and/or quality are explored in
each Team ACCESS study (see Table 1), with the overall
objectives of integrating access and quality relevant to
CRC services, and developing tools to assess these
dimensions of the healthcare system.
Access to care is measured in terms of equity [12] and
timeliness [13]. Specifically, Team ACCESS uses a
Table 3 List of administrative health databases accessed and the main variables extracted
Database Variables
Nova Scotia Cancer Registry (NSCR)/Oncology Patient
Information System
■ Patient demographics
■ Diagnosis and staging
■ Cancer center referrals and visits
■ Treatment information
■ Previous and subsequent primary cancers
■ Cancer recurrence
Mental Health Outpatient Information System (MHOIS) ■ Mental health clinic visits
■ Demographics
■ Diagnoses
Medical Service Insurance Physician Services (MSIPS) ■ Physician visits
■ Diagnoses
■ Procedures
Medical Service Insurance (MSI) Insured Patient Registry ■ Patient demographics
■ Enrollment status
■ Program eligibility dates
Licensed Provider Registry ■ Physician demographics
■ Physician specialty
■ Educational information
Vital Statistics ■ Patient demographics
■ Dates of death
■ Cause of death
Discharge Abstract Database (DAD) ■ Hospital discharges
■ Diagnoses
■ Procedures
Canadian 2001 Census Data Neighborhood or community level measures:
■ Education
■ Income
■ Rural/urban residency
Seniors’ PharmaCare Prescriptions (SP) Prescription data for individuals 65 years and older:
■ Drug ID
■ Cost
■ Amount
Community Services Prescriptions (CSP) Prescription data for individuals less than 65 years who are enrolled in a provincial
income assistance program:
■ Drug ID
■ Cost
■ Amount
Nova Scotia Breast Screening Program ■ Procedure dates
■ Procedure types
■ Screening results
■ Diagnoses
Cervical Cancer Prevention Program ■ Smear dates
■ Diagnosis dates
■ Healthcare professional specialty
Capital Health Radiology Department
(CHRD)
■ Radiology procedure codes
■ Procedure dates
Palliative Care Programs (PCP)* ■ Referral/enrollment date into a formal PCP
* Only available for the two districts with formal PCPs (i.e., Capital District Health Authority and Cape Breton District Health Authority)
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who should be receiving care, according to clinical prac-
tice guidelines (CPGs) and patients’ needs profiles, are
receiving it in a timely manner (according to CPGs and
established benchmarks). At each stage along the cancer
care continuum, the effect of various factors (i.e., age,
sex, clinical, geographical and socioeconomic factors,
and special needs of vulnerable populations [15]) on
access to CRC services is investigated. Quality is
assessed using documented cancer care quality indica-
tors (QIs) [16] and/or adherence to CPGs. Where CPG
adherence is low, reasons for non-adherence are being
explored. Such reasons have been studied using the
linked administrative data or, in certain situations, have
required a focused chart review. To maintain patient
confidentiality, chart reviews are undertaken in partner-
ship with the NSCR, which holds the key for the unique
study ID, with data subsequently linked in the manner
described above.
3.5.2. Covariates
All of our studies examine the influence of geography (e.
g., urban/rural residence, health district, and distance to
specialized services) as well as other patient characteris-
tics (e.g., age, sex, cormorbidity, and neighborhood
socioeconomic status) on the access and quality measure
studied. To maintain methodological consistency across
studies, team members collaborated to define the fol-
lowing covariates:
1) Comorbidity is assessed using a comorbidity score
and a cancer history variable. A modified list of comor-
bidities was created using those identified by Elixhauser
et al [17], with coding (ICD-9-CM and ICD-10)
developed by Quan et al [18]. Cancer-related comorbid-
ities were excluded, resulting in a list of 28 comorbid-
ities. Using this list, an unweighted comorbidity count
was obtained for each individual by examining hospital
discharge records for two years prior to the index CRC
diagnosis to 30 days after diagnosis (potential score: 0-
28). Using NSCR data, a cancer history variable was cre-
ated by counting each individual’s previously diagnosed
primary cancers. The comorbidity score and the cancer
history variable are used as separate covariates for statis-
tical analyses.
2) In addition to examining several variables indepen-
dently (e.g., median household income, education), we
use a deprivation index to measure socioeconomic status.
This index includes both material deprivation and social
deprivation as previously described by Townsend [19].
Using the “Quebec Model” [20], six indicators of material
and social deprivation (proportion of persons with a high
school diploma, employment/population ratio, average
income, proportion of persons living alone, proportion of
single parent families, and proportion of separated,
divorced, and widowed persons) were extracted from
census data. These indicators were used to generate
material and social deprivation values for patients’ census
dissemination areas (DAs). Index values range between 0
and 4, with 4 being the least deprived. Patient postal
codes at the time of diagnoses are linked, via the Postal
Code Conversion File Plus (PCCF
+) [21], to a specific DA
(as defined by 2001 census data) and assigned the asso-
ciated deprivation index values for that area.
3) Rurality is defined using the Statistical Area Classi-
fication (SACtype) and the Metropolitan and Census
Figure 2 Data linkage.
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developed by Statistics Canada to distinguish rural and
urban areas [22,23]. Patients’ postal codes obtained at the
time of diagnoses were inputted into the PCCF
+ [21] to
obtain a SAC type/MIZ value. If a patient resides in a
census metropolitan area (CMA) or census agglomera-
tion (CA), or in a zone that is strongly influenced by a
CMA or CA, his/her location of residence is considered
urban. A rural residence is defined as being located in a
zone that is not strongly influenced by a CMA or CA.
4. Results/Discussion
The development of Team ACCESS represents a unique
approach to cancer research, and specifically to CRC
research. Prior to Team ACCESS, a formal research col-
laboration of this magnitude had not existed in NS, lim-
iting the quality and breadth of CRC research
conducted in the province. In addition, collaborations
and partnerships have been established with local, pro-
vincial, and national cancer groups/organizations that
further improve our research capacity by providing
opportunities for dialogue on CRC and ongoing feed-
back, and thus contributing to our understanding of the
issues that affect the cancer care system and the patients
who use it.
Overall, Team ACCESS has made substantial contribu-
tions to CRC research. The first notable contribution
being the development of research capacity in NS by
assembling an interdisciplinary team, mentoring clini-
cians (with limited research experience), and training
graduate students (MSc, PhD, and post-doctoral fellows)
in cancer health services research. Second, by staging all
CRC cases diagnosed in NS between 2001 and 2005,
population-level stage data are available for a 5-year
time period. Since treatment for CRC depends upon the
stage at diagnosis [7], such data are vital to examining
quality of care issues in CRC. Third, the creation of the
Team ACCESS database linkage permits a thorough
assessment of health system utilization in relation to
CRC across the entire continuum of cancer care.
In addition to conducting research, Team ACCESS is
focused on effecting change in the health care system
through knowledge translation (KT) activities and colla-
borations with leaders in cancer research and cancer
services. Specifically, we have taken an integrated KT
approach by involving decision-makers in the develop-
ment, conduct, and interpretation phases of research.
We anticipate this approach will advance CRC care in
the province in two ways: 1) by helping decision-makers
facilitate changes in CRC programs and services based
on the research findings; and 2) by helping researchers
align their research questions and studies with issues
relevant to the local decision-making communities.
These contributions illustrate how a team approach is
essential to improving colorectal cancer services in NS.
Our assessment of inequity in the colorectal cancer care
system further exemplifies the importance of a team
approach. Adopting a needs-based approach to inequity
analysis, and moving beyond studying variations in care
to understanding whether the variations are based on
patients’ needs or some non-need factors (e.g., sex,
socio-economic status), has required expertise from a
diverse team - specifically, researchers and analysts to
facilitate database linkage, experts in inequity analysis
and the specific analytic techniques (e.g., horizontal
inequity index), oncologists with specific clinical knowl-
edge (e.g., related to curative and palliative therapies) to
help define need versus non-need variables and then
appropriately interpret the findings, and individuals with
knowledge translation experience to help translate the
findings and their implications to the clinical and deci-
sion-making communities.
Our study of inequity moved beyond studying varia-
tions in care, to examining whether these variations in
care are based on patients’ needs or some non-need fac-
tors (e.g., sex, socio-economic status). This needs-based
approach to inequity analysis has required expertise
from a diverse team- researchers and analysts to facili-
tate database linkage, experts in inequity analysis and
the specific analytic techniques (e.g., horizontal inequity
index), oncologists with specific clinical knowledge (e.g.,
related to curative and palliative therapies) to help
define need versus non-need variables and then appro-
priately interpret the findings, and individuals with
knowledge translation experience to help translate the
findings and their implications to the clinical and deci-
sion-making communities.
Our research has identified several limitations in data
availability and capture in our province. Specifically,
direct access to laboratory data was not available and
chemotherapy data were incomplete. Regarding the lat-
ter, chemotherapy can be administered on an outpatient
basis, often by nurses [8,24], without an associated phy-
sician billing. We have performed a chart review to
obtain complete chemotherapy data. Moreover, several
of the databases are not population-based (i.e., CHRD,
PCP, and PharmaCare), but rather are limited to certain
jurisdictions or patient populations (e.g., those 65 years
of age and older), limiting our capacity to report upon
diagnostic imaging, palliative care, and medication use
for the entire province.
Team ACCESS developed out of a recognized need to
study and improve access to quality CRC services in NS.
The significance of this team is underscored by the
involvement of many key decision/policy-makers, clini-
cal leaders, and senior researchers from other disciplines
(e.g., epidemiology, database analysis, equity analysis) to
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Page 7 of 8work on this topic. We anticipate that the skills, tools,
and knowledge generated from our work will also
advance the study of other cancer disease sites in NS.
Our approach may also be adapted to study other
chronic conditions and understand issues regarding
access to and quality of care, and their impact on out-
comes, in these patient populations.
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